![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2019 15:06 | It will clearly work up to the Manchester exhibition. Then with the increased visibility the share ought to react accordingly. | ![]() hazl | |
23/8/2019 13:37 | Ditto ! That,s why LTH are so apprehensive on the ability of AR & his Cronies to pull this one off , I assume majority of regulars on here were Gutted regards the placing Fiasco ,As it was a case of " Oh No ! Not again ,, What should have been an eazzzzzy ( They had it on the tee ) highly lucrative run up to launch ,AR Masterminds yet another " Shot in the foot " stunt ,I mean just how bad a manager is that Geezer ! Hopefully he will be nowhere near Bleepa and TO with a designated specialist PR team will be spearheading the Management Have to say today,s hxxps://t.co/c4E5UHW Contribution from New is just what we want to be reading | ![]() botak54 | |
23/8/2019 13:32 | This wont be going anywhere until after the placing shares hit the market and then expect a drop. After the presentation and hopefully a number of take ups then the share price will react in a positive manner. | ![]() digger2779 | |
23/8/2019 13:27 | One thing to bear in mind peeps, any order over £50k placed by the NHS has to go out to tender, are there any competitors and have feedback patented the technology? | sonie01 | |
23/8/2019 13:18 | Botak Absolutely agree that this should be 4-5p before the show but as you said the market are aware of this company's track record. Get this right and the past will be forgiven, get this wrong and there should be a class litigation act against the BoD | sonie01 | |
23/8/2019 12:59 | sonie just hope the BoD are on the ball with this one I sincerely believe that,s why we are not in the mid 3/4,s now , Market is aware of there past performance ,However NHS + an initial 1 hospital Global ( India ) contract and there track record will be confined to the history books and it will indeed be boom time | ![]() botak54 | |
23/8/2019 12:25 | Bob I'm sure it's up too the individual trusts, potentially tho I can see a blanket contract with the NHS which would mean only one thing.........boom time, just hope the BoD are on the ball with this one | sonie01 | |
23/8/2019 11:06 | Let's put it all behind us then. | ![]() hazl | |
23/8/2019 11:05 | Big Thanks newto post 10.50 It actually reads in a very appealing and encouraging way and appeases a lot of concerns on patient data and security issues on a misplaced mobile device | ![]() botak54 | |
23/8/2019 10:55 | Hazl, re post 2374, REALLY? I thought you had genuinely misunderstood and I was just trying to help. If I saw it in a different way to what you intended then others would. Scoring points is not on my agenda and I don't believe BBs, twitter or any social media should be used for investment. I found the technical article about Cadran just that. I found it too technical but others might find it interesting. I don't know how my comment could be construed as "snide" I am not a huge holder here; certainly not as many as Gymratt, davydoo and several others who have mentioned their holdings on here. I just find researching companies a real interest and I don't mind sharing my research. That's why I post. If you make a few thousand on a trade with or without my research I will be very pleased. | ![]() ged5 | |
23/8/2019 10:50 | #FDBK HOT OFF THE PRESS 23 August 2019 08:31 @BleepaMe How a messaging service doubles up as a medical device by Ian Bolland | ![]() newtothisgame3 | |
23/8/2019 10:44 | Hmm.....seem to be bringing out the late trades.... | ![]() hazl | |
23/8/2019 10:36 | Thanks LR2 for posting that link. I thought when I started reading it we were to get an answer to software protection but alas it was just about data protection. I suppose data protection is more important to NHS trusts so perhaps correct to focus on that as they start the process of marketing. Software protection is more a concern for shareholders. | ![]() ged5 | |
23/8/2019 10:35 | Cheeky 1 trade for those who believe in horoscopes.. | ![]() dplewis1 | |
23/8/2019 10:14 | Now I have got that out the way I do hope we can start again. | ![]() hazl | |
23/8/2019 10:13 | Just to get the last thing out of the way. Botak54 what a condescending and unlikely factual post. So you help other posters? Let's see 115 posts in 7 years...that's 17 a year of helpful posts apparently, yet no followers? Better think again then, unless you have other aliases of course....... | ![]() hazl | |
23/8/2019 10:03 | Sorry Bob, I don't have that info. Too busy with serious family matters to do much research these days. | ![]() lr2 | |
23/8/2019 10:00 | Yes bob that says it all really. | ![]() hazl | |
23/8/2019 09:55 | Morning lr2, do you know whether the Bleepa contract will be with NHS, individual Trusts or individual doctors etc? The future of FDBK seems to depend upon the success of Bleepa and it will be interesting to see an announcement post expo on the level of takeup to date and ongoing potential. Bleepa is really the new kid on the block and lths will recall the real prize was getting TexRAD clinically adopted. I await with interest TOs update on the commercial prospects of this. If Bleepa and TexRAD can legitimately lead the way commercially in their respective areas then FDBK has a very bright future and even with the new shares is very cheap at these levels. Lths however have long memories. | ![]() bobd29 | |
23/8/2019 09:40 | Thank you LR2 a relevant and helpful post. | ![]() hazl | |
23/8/2019 09:39 | As usual here,everybody trying to score points. If I have inadvertently missed out something on my post, that comes of posting late and apologies but surely all of us want the same out come of success for Feedback here? This bb needs to pull together more rather than making snide remarks about 'those more technically-minded'. I mistook you for one of the more helpful posters GED my mistake. I have been on these boards for a long time with some success and know that you are unlikely to attract new investors, who are just passing through, by that attitude. | ![]() hazl | |
23/8/2019 09:34 | After the Bleepa: App aims to improve security and treatment ease Ian Bolland caught up with Dr Tom Oakley, CEO of Feedback, about its medical grade imaging app Bleepa, which will be launched at the NHS Expo on 4-5 September in Manchester. | ![]() lr2 | |
23/8/2019 08:44 | No! Your post 2368 makes it look as though the first order through GE Healthcare is for Cadran. You've missed out "for TexRAD". As far as I know the link is the only RNS for a Cadran order. However on the website:- "Cadran was originally developed to support the needs of Royal Papworth Hospital, the UK’s largest specialist cardiothoracic hospital. Now Cadran facilitates doctors in some of the UK’s leading hospitals to use medical images for diagnosis, treatment planning, response measurement and knowledge sharing within multi-disciplinary teams." But as said in 10th July 2019 RNS;- "However, it is currently positioned in a competitive market that shows little opportunity for future growth." For the more technically minded:- | ![]() ged5 | |
23/8/2019 08:38 | hazl If you did 4 years in Uni studying criminology,Would you expect to Graduate in Dressmaking & Design ? The majority on this bb have a preference to help other posters Think yourself lucky , Most of us learnt the hard way and are still burning All the Best in your investments | ![]() botak54 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions